Publikationen
Zeitschriftenartikel (12)
2020
Zeitschriftenartikel
74 (12), S. 811 - 812 (2020)
History of BCG Vaccination Recommendations in East and West Germany from 1951 to Date. Pneumologie
Zeitschriftenartikel
74 (7), S. 412 - 416 (2020)
DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19* (*Offizielle Bezeichnung der Erkrankung durch das neuartige Coronavirus SARS-CoV-2, severe acute respiratory syndrome coronavirus 2) . DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2). Pneumologie
Zeitschriftenartikel
71 (1), S. 30 - 40 (2020)
Changes in Transcript, Metabolite, and Antibody Reactivity During the Early Protective Immune Response in Humans to Mycobacterium tuberculosis Infection. Clinical Infectious Diseases
Zeitschriftenartikel
130 (6), S. 2789 - 2799 (2020)
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus. Journal of Clinical Investigation
Zeitschriftenartikel
10 (1), 8629 (2020)
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Scientific Reports
Zeitschriftenartikel
10 (1), 8640 (2020)
Author Correction: The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis. Scientific Reports
Zeitschriftenartikel
202 (5), S. 730 - 744 (2020)
Platelets Restrict the Oxidative Burst in Phagocytes and Facilitate Primary Progressive Tuberculosis. American Journal of Respiratory and Critical Care Medicine
Zeitschriftenartikel
13 (3), dmm041954 (2020)
FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity. Disease Models & Mechanisms
Zeitschriftenartikel
5, 29 (2020)
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination. npj Vaccines
Zeitschriftenartikel
11, 316 (2020)
Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology. Frontiers in immunology
Zeitschriftenartikel
27 (2), S. 238 - 248.e7 (2020)
Aryl Hydrocarbon Receptor Modulation by Tuberculosis Drugs Impairs Host Defense and Treatment Outcomes. Cell Host & Microbe
Zeitschriftenartikel
63 (1), S. 56 - 64 (2020)
Neue Impfstoffe gegen Tuberkulose [New vaccines against tuberculosis]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz